News archive

Lifecare Semi Annual report: Towards market readiness

August 23, 2023
Lifecare has shown major progress in our plan to bring the smallest Continuous Glucose Monitor (CGM) system to the market. Testing in live tissue, implementation of Quality Management System and set up of manufacturing capabilities form the three main pillars in our market-oriented development. – The results from studies concluded in 1H 2023 and the […]
Read more

Lifecare sensor longevity experiment concluded: 6 months operational lifetime

July 18, 2023
Lifecare’s Sencell Continuous Glucose Monitoring (CGM) sensor has reached an operational lifetime of more than 24 weeks (172 days), with a sensor chemistry shelf life of almost 27 weeks (187 days). This achievement confirms the Sencell CGM technology potential and validates Lifecares expectation of a minimum 6-month sensor longevity. The longevity results were achieved by […]
Read more

Proof-of-Concept Study Results presented at American Diabetes Association Scientific Session 2023

June 26, 2023
Data from Lifecare’s Clinical Development Study LFC-SEN-001 was presented at the American Diabetes Association (ADA) Scientific Sessions 2023. Lifecare’s poster presentation reveals the study background, methods, and results. The results include an impressive mean average of absolute error (MARD) of 9,6%, positioning Lifecares’s Sencell technology with an accuracy that is acceptable for therapeutic (medical) decisions […]
Read more

Lifecare study confirm clinical accuracy in line with gold standard

June 20, 2023
Data from Lifecare’s Clinical Development Study LFC-SEN-001 confirm that the Company’s Continuous Glucose Monitoring (CGM) system (Sencell) has a solid clinical accuracy: the mean average of absolute error (MARD) between Sencell and matched relative reference values was 9,6%.     In context, regulatory authorities expect a MARD below 10% to acknowledge CGM for therapeutic (medical) decisions […]
Read more

Lifecare launches spin-off company with successful veterinary

May 30, 2023
Lifecare is launching a new company called Lifecare Veterinary. Now man’s best friend will also benefit from the same innovation.   – Our main focus will still be the development of the sensor for people with diabetes, increasing their quality of life. This is not, however, counterproductive to helping our pets in parallel to the […]
Read more

Information from Lifecare – May 2023

May 12, 2023
Finalized successful Sencell clincal study Today we can announce that we have finalized the Sencell Clinical Development Study (LFC-SEN-001) and it reveals accurate sensor performance in human subjects. – This is a very important step in the right direction to develop the next generation Continuous Glucose Monitor (CGM) for people with diabetes, says CEO Joacim Holter. […]
Read more

Update on Sensor longevity 

April 11, 2023
Today, Lifecare is pleased to announce that a sensor first used in our ongoing Clinical Development Study has confirmed an operational longevity of 12 weeks in a continued laboratory (in vitro) set up. This is yet another important milestone in the development of our Sencell technology for Continuous Glucose Monitoring (CGM).     The achievement was […]
Read more

Update on Clinical Development Study

March 31, 2023
The Clinical Development Study with the Sencell sensor will continue for a few more weeks. – We operate complex and pioneering sensor technology and strive to ensure high quality at all stages of the process. We therefore want to extend the Clinical Development Study by a few weeks more than previously communicated, says CEO Joacim […]
Read more

Annual Report 2022 – Important milestone achievements

March 28, 2023
For Lifecare 2022 was characterized by confirmation of the technology, Clinical Development Study, and building an organization that makes us even more robust and competent to face upcoming challenges. – Important milestone achievements naturally provide a good basis for the ongoing work related to the glucose sensor, CEO Joacim Holter states. Lifecare’s Annual Report 2022 […]
Read more

Successful ISO audit at Lifecare Laboratory in Germany

March 23, 2023
Lifecare is pleased to announce that its wholly owned subsidiary Lifecare Laboratory GmbH in Mainz, Germany, has been successfully audited as part of the upcoming ISO certification. “It is reassuring that our operational organization has passed this audit without any major findings. This is a good fundament for our continued work on regulatory processes.” says […]
Read more